Please use this identifier to cite or link to this item:
|Title:||Effects of race and ethnicity on depression treatment outcomes: The CO-MED trial|
|Source:||Lesser, I.M.,Khan, A.,Zisook, S.,McGrath, P.,Gaynes, B.N.,Warden, D.,Wisniewski, S.R.,Rush, A.J.,Luther, J.F.,Trivedi, M.,Fava, M. (2011-10). Effects of race and ethnicity on depression treatment outcomes: The CO-MED trial. Psychiatric Services 62 (10) : 1167-1179. ScholarBank@NUS Repository. https://doi.org/10.1176/appi.ps.62.10.1167|
|Abstract:||Objective: The investigators examined whether outcomes differ by race-ethnicity for patients with major depressive disorder in acute- (12 weeks) and continuation-phase (weeks 12-28) treatment with one of two antidepressant combinations or one selective serotonin reuptake inhibitor. Methods: This single-blind, seven-month prospective, randomized trial enrolled 352 non-Hispanic white (59%), 169 black (28%), and 79 white Hispanic (13%) participants from six primary and nine psychiatric care U.S. sites. Patients had nonpsychotic chronic or recurrent major depressive disorder (or both) of at least moderate severity. Escitalopram plus placebo, bupropion sustained-release plus escitalopram, or venlafaxine extended-release plus mirtazapine were delivered according to measurementbased care. The primary outcome was remission (last two consecutive 16-item Quick Inventory of Depressive Symptomatology-Self- Report ratings|
|Source Title:||Psychiatric Services|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 20, 2018
checked on Feb 23, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.